Organon Canada announces the Approval and Availability of NDUVRA® (tapinarof cream), 1%, a New Steroid-Free Topical Treatment for Moderate to Severe Atopic Dermatitis in Adult and Pediatric Patients 2 Years of Age and Older – Company Announceme
, /CNW/ -- Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA ® (…
Latest · AZ Weekly Post










